Prometheus Laboratories is enrolling patients for Proclivity 01, a multi-center study of Proleukin (High Dose Interleukin-2 (HD IL-2)) combined with vemurafenib therapy in patients with Braf V600 mutation-positive metastatic melanoma (mM). ...
Tags: Prometheus, Proclivity 01 Study
Forest Laboratories and Almirall have reported positive results from the ACLIdinium/FORMoterol fumarate combination for Investigative use in the treatment of moderate to severe COPD (ACLIFORM/COPD) Phase III study. ACLIFORM/COPD is the ...
ACE Group-owned risk management services company, ESIS has announced expansion of its global claims servicing platform through enhanced network and new global catastrophe claims services. Besides servicing over 165 countries worldwide, ...
Tags: ESIS, Claims Servicing Platform
The US food and drug administration (FDA) has approved Janssen's Invokana (canagliflozin) for the treatment of adults with type 2 diabetes. Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic ...
Abbott has presented clinical study data from a Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II ) High Surgical Risk cohort of its MitraClip System for the treatment of mitral regurgitation (MR). The CE-marked catheter-based ...
Tags: clinical study, MitraClip System, medical
EarlySense is demonstrating its contact-free, continuous, patient safety monitoring system at the Healthcare Information and Management Systems Society (HIMSS) trade show, which is being held at the Ernest N. Morial Convention Center in New ...
Hospira is voluntarily recalling multiple lots of five different injections, due to reports of faulty packaging and contamination. According to the firm, the recall was took place as the consumers have reported that one lot of ...
Tags: Hospira, Injections, Medicine
Covidien has completed patient enrollment in its VISIBILITY and DURABILITY Iliac stent clinical study series. The prospective, multinational, multicenter studies, which have enrolled 150 patients from 23 centers in the US and Europe, are ...
Critical Pharmaceuticals has completed second clinical trial on CP024 intranasal growth hormone. CP024 growth hormone nasal spray was safe and well tolerated in the study that administered six dose levels of CP024 in healthy subjects. ...
Novartis Consumer Health has announced that it is voluntarily recalling certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactured in the United States before December 2011. Novartis Consumer Health has ...
Tags: tamper evident seal, bottle sizes, bottle
Velomedix has completed enrollment of the first patient in Velocity clinical study of its rapid therapeutic hypothermia system for treating acute myocardial infarction (AMIs or heart attacks). Using a peritoneal-based approach, the ...
Tags: Velomedix, Velocity clinical study, rapid therapeutic hypothermia system
Takeda Pharmaceutical has received FDA approval for three new type 2 diabetes therapies Nesina (alogliptin) and fixed-dose combinations Oseni (alogliptin and pioglitazone) and Kazano (alogliptin and metformin HCl). Takeda expects to ...
Tags: FDA, diabetes therapies, Pharmaceuticals
Nymox Pharmaceutical has reported new positive data from Phase 3 study, designed to evaluate the safety and efficacy of the reinjection of NX-1207 for benign prostatic hyperplasia (BPH). The NX02-0020 study participants included 192 ...
Tags: Nymox Pharmaceutical, BPH, Phase 3 study
American pharmaceutical company BioDelivery Sciences (BDSI) has completed the safety and tolerability trial of BEMA Buprenorphine/Naloxone (BNX), which is indicated for the treatment of opioid dependent patients. BDSI claims that BNX, ...
Tags: BioDelivery Sciences, BEMA Buprenorphine, opioid dependent patients
On these short winter days, some people might find themselves eyeing caffeinated energy drinks for a little boost. But perk up your ears: Emergency room visits for problems related to energy drinks have risen sharply, particularly for ...
Tags: caffeinated energy drinks, healthcare, drug related hospital emergency